Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05369546 · ClinicalTrials.gov registry record
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
A clinical trial of Breast Cancer, sponsored by University of Hawaii.
- Recruiting
- Registry status
- 600
- Enrollment target
- 3
- Study locations
NCT05369546: Recruiting study of Breast Cancer, sponsored by University of Hawaii.
NCT05369546 is a study of Breast Cancer that is actively recruiting participants, run by University of Hawaii. The registered enrollment target is 600 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05369546, a study of Breast Cancer, is actively recruiting participants, sponsored by University of Hawaii.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective is to better identify suspicious breast lesions that need to be biopsied for malignancy in women currently recommended for biopsy. The long-term goal is to reduce unnecessary biopsies and increase biopsy yield. To do this, the investigators have developed an innovative way to use FDA-approved breast imaging protocols to acquire multispectral images to measure the composition of suspicious breast lesions. The central hypothesis is that breast tissue composition in combination with analysis of morphological and textural tissue characteristics on digital breast tomosynthesis (DBT) imaging will yield significantly higher breast cancer specificity than conventional interpretation of DBT alone.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST q3CB
Study Locations (3)
Hawaii
- Hawaii Radiology Associates, LTD (East Hawaii Women's Imaging Center) - Hilo
- The Queen's Medical Center - Honolulu
Florida
- H. Lee Moffitt Cancer Center & Research Institute, Inc. - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-07 |
What NCT05369546 shows while recruiting
NCT05369546 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which q3CB is the first listed.
NCT05369546 reports a single indexed study location in Hawaii, Florida.
Frequently Asked Questions
What is clinical trial NCT05369546 about?
NCT05369546 is a clinical study titled "Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis". The objective is to better identify suspicious breast lesions that need to be biopsied for malignancy in women currently recommended for biopsy. The long-term goal is to reduce unnecessary biopsies and increase biopsy yield. To do this, the investigators have developed an innovative way to use FDA-a...
What is the current status of trial NCT05369546?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2022-08-01. Estimated completion is 2026-07.
What conditions does trial NCT05369546 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05369546?
The interventions under investigation include: q3CB (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05369546?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05369546 being conducted?
This trial has 3 study locations across Florida, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05369546's enrollment target sits among peer trials
600 177th of 1224 higher than 1,044 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI